BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29474405)

  • 21. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
    Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
    Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression.
    Favretto G; Souza LM; Gregório PC; Cunha RS; Maciel RAP; Sassaki GL; Toledo MG; Pecoits-Filho R; Souza WM; Stinghen AEM
    J Vasc Res; 2017; 54(3):170-179. PubMed ID: 28472795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography.
    de Loor H; Meijers BK; Meyer TW; Bammens B; Verbeke K; Dehaen W; Evenepoel P
    J Chromatogr A; 2009 May; 1216(22):4684-8. PubMed ID: 19394619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.
    Sun CY; Chang SC; Wu MS
    Kidney Int; 2012 Apr; 81(7):640-50. PubMed ID: 22237753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indoxyl sulfate and p-cresyl sulfate in chronic kidney disease. Could these toxins modulate the antioxidant Nrf2-Keap1 pathway?
    Stockler-Pinto MB; Fouque D; Soulage CO; Croze M; Mafra D
    J Ren Nutr; 2014 Sep; 24(5):286-91. PubMed ID: 24480117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein-bound uremic toxins - biological effects and impact on morbidity in patients with chronic kidney disease.
    Gomółka M; Niemczyk S
    Przegl Lek; 2017; 74(3):110-4. PubMed ID: 29694770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin.
    Meijers BK; De Preter V; Verbeke K; Vanrenterghem Y; Evenepoel P
    Nephrol Dial Transplant; 2010 Jan; 25(1):219-24. PubMed ID: 19692415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
    Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
    ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
    Mutsaers HA; Caetano-Pinto P; Seegers AE; Dankers AC; van den Broek PH; Wetzels JF; van den Brand JA; van den Heuvel LP; Hoenderop JG; Wilmer MJ; Masereeuw R
    Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with pravastatin attenuates oxidative stress and protects osteoblast cell viability from indoxyl sulfate.
    Iwasaki Y; Yamato H; Fukagawa M
    Ther Apher Dial; 2011 Apr; 15(2):151-5. PubMed ID: 21426507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant.
    Miyamoto Y; Watanabe H; Otagiri M; Maruyama T
    Ther Apher Dial; 2011 Apr; 15(2):129-31. PubMed ID: 21426502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
    Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
    Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-κB, p53, ERK, and JNK in proximal tubular cells.
    Shimizu H; Bolati D; Higashiyama Y; Nishijima F; Shimizu K; Niwa T
    Life Sci; 2012 Apr; 90(13-14):525-30. PubMed ID: 22326498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis.
    Lee TH; Park D; Kim YJ; Lee I; Kim S; Oh CT; Kim JY; Yang J; Jo SK
    Int J Mol Med; 2020 Apr; 45(4):1130-1140. PubMed ID: 32124946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
    Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
    Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
    Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
    Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Mass Spectrom (Tokyo); 2013; 2(Spec Iss):S0017. PubMed ID: 24349936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Numerous protein-bound solutes are cleared by the kidney with high efficiency.
    Sirich TL; Aronov PA; Plummer NS; Hostetter TH; Meyer TW
    Kidney Int; 2013 Sep; 84(3):585-90. PubMed ID: 23636170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.